Apiam Animal Health Limited (ASX:AHX) FY22 Results Release
Apiam Animal Health Limited (ASX:AHX) is pleased to release its full year results for the 12-months to 30 June 2022 (FY22).
Companies in the News
Biotech
Nanollose Limited (ASX:NC6) Annual Report
The period marked a transformational year for Nanollose Limited (ASX:NC6) (FRA:N0L), underpinned by a series of critical R&D breakthroughs.
Apiam Animal Health Limited (ASX:AHX) FY22 Reporting Date and Investor Webinar Notification
Apiam Animal Health Limited (ASX:AHX) will release its financial results for the twelve months ended 30 June 2022 on Monday August 29 2022.
Nanollose Limited (ASX:NC6) Codi Group Cooperation Agreement Extended
Nanollose Limited (ASX:NC6) (FRA:N0L) is pleased to advise that it has extended its Cooperation Agreement with Codi International BV, part of the Codi Group ("Codi"), for a further three years.
Apiam Animal Health Limited (ASX:AHX) Expands Commitment to Racing Industry with Naming Sponsorship of Bendigo Racecourse
Within racing circles, Bendigo Racecourse is commonly referred to as the Nursery of Champions due to the amount of legends that have started their careers at the famous track now named Apiam Bendigo racecourse.
VGI Health Technology Limited (NSX:VTL) June 2022 Quarterly Update
The Directors of VGI Health Technology Limited (NSX:VTL) are pleased to provide the following update for the quarter ending 30 June 2022.
Nanollose Limited (ASX:NC6) Quarterly Activities Report
Nanollose Limited (ASX:NC6) (FRA:N0L) a leading biomaterials company, focused on commercialising scalable technology to create fibres and fabrics with minimal environmental impact, is pleased to provide shareholders with an overview of its activities for the period ended 30 June 2022.
◂Previous Page
Biotech Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
Oil Gas & Energy
- State Gas Limited (ASX:GAS) Advances Rolleston West
- Central Petroleum Limited (ASX:CTP) Operations and Activities Update
- Beetaloo Energy Australia Limited (ASX:BTL) Traditional Owners Consent to the Sale of Appraisal Gas
- Beetaloo Energy Australia Limited (ASX:BTL) Commences Carpentaria-5H Hydraulic Stimulation Operations
- Empire Energy Group Ltd (ASX:EEG) Change of Name and ASX Code
- VIDEO: Empire Energy Group Limited (ASX:EEG) Shareholder Support Erupts as Gas Production Draws Closer
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) AMA Grants Reimbursement Code for Next-Gen PromarkerD Test
- Proteomics International Laboratories Ltd (ASX:PIQ) Funding Boost for Precision Diagnostics Proteomics Facility
- Proteomics International Laboratories Ltd (ASX:PIQ) First Patent for Endometriosis Blood Test - Granted in Japan
- Proteomics International Laboratories Ltd (ASX:PIQ) Next-gen PromarkerD test system released for predicting Diabetic Kidney Disease
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Launched into the US at Major Diabetes Conference
- Proteomics International Laboratories Ltd (ASX:PIQ) A Landmark in Non-Invasive Esophageal Cancer Diagnosis
Social Media
